Scout Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,334
Closed -$3.32M 209
2022
Q4
$3.32M Sell
29,334
-36
-0.1% -$3.95K 0.07% 199
2022
Q3
$2.37M Sell
29,370
-99,571
-77% -$8.43M 0.05% 213
2022
Q2
$9.61M Buy
128,941
+93,545
+264% +$8.54M 0.19% 136
2022
Q1
$4.53M Sell
35,396
-52,944
-60% -$5.79M 0.07% 208
2021
Q4
$11.9M Sell
88,340
-74,708
-46% -$10.7M 0.17% 165
2021
Q3
$22.3M Sell
163,048
-70,732
-30% -$8.92M 0.33% 114
2021
Q2
$25M Buy
233,780
+6,440
+3% +$618K 0.37% 98
2021
Q1
$20.4M Buy
227,340
+24,836
+12% +$2.33M 0.31% 124
2020
Q4
$18.7M Buy
202,504
+133,132
+192% +$11.9M 0.34% 118
2020
Q3
$7.15M Sell
69,372
-1,888
-3% -$197K 0.16% 211
2020
Q2
$7.22M Sell
71,260
-1,428
-2% -$128K 0.17% 190
2020
Q1
$4.89M Buy
+72,688
New +$4.52M 0.15% 190

Other funds holding DXCM

Scout Investments's DXCM Position: Q1 2023 in Review

Scout Investments sold out of DexCom (DXCM) in Q1 2023, closing a stake of 29,334 shares — an estimated $3.32M sold.

Scout Investments first reported a position in DXCM in Q1 2020 and held it in 12 quarters. The position peaked at $25M in Q2 2021. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Scout Investments reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Scout Investments sold 29,334 DexCom shares in Q1 2023, an estimated $3.32M.
  • Scout Investments first reported a position in DexCom in Q1 2020 and held it in 12 quarters.
  • Scout Investments's DexCom position peaked at $25M in Q2 2021.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Scout Investments's 13F filing for Q1 2023, filed 11 May 2023.